Regranion, LLC

Mount Pleasant, SC

UEI
MC1LNCYZJCK9
CAGE
5KJ68
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Minority Owned Business
  • For Profit Organization
  • Limited Liability Company
  • Subcontinent Asian (Asian-Indian) American Owned
Entity structure
Other
SAM.gov registration date
Physical address
194 Ionsborough St, Mt Pleasant, SC 29464, USA
Website
regranion.com
Founded
2009
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Novel small molecule HSP90 inhibitor for the management of atopic dermatitis R43AR077503 National Insititue of Arthritis and Musculoskeletal and Skin Diseases (NIH) $252,131
A novel topical HSP90 inhibitor (ctxt-102) in the treatment of mild to moderate plaque psoriasis R44AR071174 National Insititue of Arthritis and Musculoskeletal and Skin Diseases (NIH) $1,225,570

Quick answers

Is Regranion, LLC registered in SAM.gov?

Yes. Regranion, LLC's SAM.gov registration is active through June 16, 2027.

What is Regranion, LLC's most recent federal award?

Regranion, LLC's most recent federal grant award is Novel small molecule HSP90 inhibitor for the management of atopic dermatitis (R43AR077503), from National Insititue of Arthritis and Musculoskeletal and Skin Diseases (NIH), on September 15, 2020.

On GovTribe

See Regranion, LLC's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login